<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">23054400</PMID>
      <DateCompleted>
        <Year>2013</Year>
        <Month>06</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1776-260X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>7</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2012</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Targeted oncology</Title>
          <ISOAbbreviation>Target Oncol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hyperbaric oxygen therapy and cancer--a review.</ArticleTitle>
        <Pagination>
          <StartPage>233</StartPage>
          <EndPage>242</EndPage>
          <MedlinePgn>233-42</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11523-012-0233-x</ELocationID>
        <Abstract>
          <AbstractText>Hypoxia is a critical hallmark of solid tumors and involves enhanced cell survival, angiogenesis, glycolytic metabolism, and metastasis. Hyperbaric oxygen (HBO) treatment has for centuries been used to improve or cure disorders involving hypoxia and ischemia, by enhancing the amount of dissolved oxygen in the plasma and thereby increasing O(2) delivery to the tissue. Studies on HBO and cancer have up to recently focused on whether enhanced oxygen acts as a cancer promoter or not. As oxygen is believed to be required for all the major processes of wound healing, one feared that the effects of HBO would be applicable to cancer tissue as well and promote cancer growth. Furthermore, one also feared that exposing patients who had been treated for cancer, to HBO, would lead to recurrence. Nevertheless, two systematic reviews on HBO and cancer have concluded that the use of HBO in patients with malignancies is considered safe. To supplement the previous reviews, we have summarized the work performed on HBO and cancer in the period 2004-2012. Based on the present as well as previous reviews, there is no evidence indicating that HBO neither acts as a stimulator of tumor growth nor as an enhancer of recurrence. On the other hand, there is evidence that implies that HBO might have tumor-inhibitory effects in certain cancer subtypes, and we thus strongly believe that we need to expand our knowledge on the effect and the mechanisms behind tumor oxygenation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Moen</LastName>
            <ForeName>Ingrid</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway. ingrid.moen@biomed.uib.no</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stuhr</LastName>
            <ForeName>Linda E B</ForeName>
            <Initials>LE</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2012</Year>
          <Month>10</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Target Oncol</MedlineTA>
        <NlmUniqueID>101270595</NlmUniqueID>
        <ISSNLinking>1776-2596</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>S88TT14065</RegistryNumber>
          <NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015687" MajorTopicYN="N">Cell Hypoxia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019069" MajorTopicYN="N">Cell Respiration</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006931" MajorTopicYN="Y">Hyperbaric Oxygenation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2012</Year>
          <Month>5</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2012</Year>
          <Month>9</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2012</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2012</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2013</Year>
          <Month>7</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23054400</ArticleId>
        <ArticleId IdType="pmc">PMC3510426</ArticleId>
        <ArticleId IdType="doi">10.1007/s11523-012-0233-x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Michieli P. Hypoxia, angiogenesis and cancer therapy: to breathe or not to breathe? Cell Cycle. 2009;8:3291–3296. doi: 10.4161/cc.8.20.9741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/cc.8.20.9741</ArticleId>
            <ArticleId IdType="pubmed">19770588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26:225–239. doi: 10.1007/s10555-007-9055-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10555-007-9055-1</ArticleId>
            <ArticleId IdType="pubmed">17440684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris AL. Hypoxia—a key regulatory factor in tumor growth. Nat Rev Cancer. 2002;2:38–47. doi: 10.1038/nrc704.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc704</ArticleId>
            <ArticleId IdType="pubmed">11902584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holmquist L, Lofstedt T, Pahlman S. Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models. Adv Exp Med Biol. 2006;587:179–193. doi: 10.1007/978-1-4020-5133-3_16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4020-5133-3_16</ArticleId>
            <ArticleId IdType="pubmed">17163166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shannon AM, Bouchier-Hayes DJ, Condron CM, Toomey D. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev. 2003;29:297–307. doi: 10.1016/S0305-7372(03)00003-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0305-7372(03)00003-3</ArticleId>
            <ArticleId IdType="pubmed">12927570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953;26:638–648. doi: 10.1259/0007-1285-26-312-638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1259/0007-1285-26-312-638</ArticleId>
            <ArticleId IdType="pubmed">13106296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Overgaard J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck—a systematic review and meta-analysis. Radiother Oncol. 2011;100:22–32. doi: 10.1016/j.radonc.2011.03.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.radonc.2011.03.004</ArticleId>
            <ArticleId IdType="pubmed">21511351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cannito S, Novo E, Compagnone A, Valfre di Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A, Bozzo F, Cravanzola C, Bravoco V, Colombatto S, Parola M. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis. 2008;29:2267–2278. doi: 10.1093/carcin/bgn216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/carcin/bgn216</ArticleId>
            <ArticleId IdType="pubmed">18791199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thiery JP. Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–454. doi: 10.1038/nrc822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc822</ArticleId>
            <ArticleId IdType="pubmed">12189386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gill AL, Bell CNA. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM. 2004;97:385–395. doi: 10.1093/qjmed/hch074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/qjmed/hch074</ArticleId>
            <ArticleId IdType="pubmed">15208426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brizel DM, Lin S, Johnson JL, Brooks J, Dewhirst MW, Piantadosi CA. The mechanisms by which hyperbaric oxygen and carbogen improve tumor oxygenation. Br J Cancer. 1995;72:1120–1124. doi: 10.1038/bjc.1995.474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/bjc.1995.474</ArticleId>
            <ArticleId IdType="pmc">PMC2033965</ArticleId>
            <ArticleId IdType="pubmed">7577456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kinoshita Y, Kohshi K, Kunugita N, Tosaki T, Yokota A. Preservation of tumor oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging. Br J Cancer. 2000;82:88–92. doi: 10.1054/bjoc.1999.0882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1054/bjoc.1999.0882</ArticleId>
            <ArticleId IdType="pmc">PMC2363207</ArticleId>
            <ArticleId IdType="pubmed">10638972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beppu T, Kamada K, Yoshida Y, Arai H, Ogasawara K, Ogawa A. Change of oxygen pressure in glioblastoma tissue under various conditions. J Neurooncol. 2002;58:47–52. doi: 10.1023/A:1015832726054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1015832726054</ArticleId>
            <ArticleId IdType="pubmed">12160140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hopf HW, Rollins MD. Wounds: an overview of the role of oxygen. Antioxid Redox Signal. 2007;9:1183–1192. doi: 10.1089/ars.2007.1641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2007.1641</ArticleId>
            <ArticleId IdType="pubmed">17536961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feldmeier J, Carl U, Hartmann K, Sminia P. Hyperbaric oxygen: does it promote growth or recurrence of malignancy? Undersea Hyperb Med. 2003;30:1–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12841604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daruwalla J, Christophi C. Hyperbaric oxygen therapy for malignancy: a review. World J Surg. 2006;30:2112–2131. doi: 10.1007/s00268-006-0190-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00268-006-0190-6</ArticleId>
            <ArticleId IdType="pubmed">17102915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gore A, Muralidhar M, Espey MG, Degenhardt K, Mantell LL. Hyperoxia sensing: from molecular mechanisms to significance in disease. J Immunotoxicol. 2010;7:239–254. doi: 10.3109/1547691X.2010.492254.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/1547691X.2010.492254</ArticleId>
            <ArticleId IdType="pubmed">20586583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Granowitz EV, Tonomura N, Benson RM, Katz DM, Band V, Makari-Judson GP, Osborne BA. Hyperbaric oxygen inhibits benign and malignant human mammary epithelial cell proliferation. Anticancer Res. 2005;25:3833–3842.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16312043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun TB, Chen RL, Hsu YH. The effect of hyperbaric oxygen on human oral cancer cells. Undersea Hyperb Med. 2004;31:251–260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15485088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen YC, Chen SY, Ho PS, Lin CH, Cheng YY, Wang JK, Sytwu HK. Apoptosis of T-leukemia and B-myeloma cancer cells induced by hyperbaric oxygen increased phosphorylation of p38 MAPK. Leuk Res. 2007;31:805–815. doi: 10.1016/j.leukres.2006.09.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.leukres.2006.09.016</ArticleId>
            <ArticleId IdType="pubmed">17064767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawasoe Y, Yokouchi M, Ueno Y, Iwaya H, Yoshida H, Komiya S. Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma. Oncol Rep. 2009;22:1045–1050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19787219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raa A, Stansberg C, Steen VM, Bjerkvig R, Reed RK, Stuhr LE. Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumors. BMC Cancer. 2007;7:23. doi: 10.1186/1471-2407-7-23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2407-7-23</ArticleId>
            <ArticleId IdType="pmc">PMC1797183</ArticleId>
            <ArticleId IdType="pubmed">17263869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stuhr LE, Raa A, Oyan AM, Kalland KH, Sakariassen PO, Petersen K, Bjerkvig R, Reed RK. Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. J Neurooncol. 2007;85:191–202. doi: 10.1007/s11060-007-9407-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11060-007-9407-2</ArticleId>
            <ArticleId IdType="pubmed">17557137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moen I, Oyan AM, Kalland KH, Tronstad KJ, Akslen LA, Chekenya M, Sakariassen PO, Reed RK, Stuhr LE. Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model. PLoS One. 2009;4:e6381. doi: 10.1371/journal.pone.0006381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0006381</ArticleId>
            <ArticleId IdType="pmc">PMC2712688</ArticleId>
            <ArticleId IdType="pubmed">19636430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng ZR, Zhong WH, Liu J, Xiao PT. Effects of the combination of hyperbaric oxygen and 5-fluorouracil on proliferation and metastasis of human nasopharyngeal carcinoma CNE-2Z cells. Undersea Hyperb Med. 2010;37:141–150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20568543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Godman CA, Joshi R, Giardina C, Perdrizet G, Hightower LE. Hyperbaric oxygen treatment induces antioxidant gene expression. Ann N Y Acad Sci. 2010;1197:178–183. doi: 10.1111/j.1749-6632.2009.05393.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1749-6632.2009.05393.x</ArticleId>
            <ArticleId IdType="pubmed">20536847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Y, Lee CS, Wu J, Koch CJ, Thom SR, Maity A, Bernhard EJ. Effects of hyperbaric oxygen exposure on experimental head and neck tumor growth, oxygenation, and vasculature. Head Neck. 2005;27:362–369. doi: 10.1002/hed.20169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hed.20169</ArticleId>
            <ArticleId IdType="pubmed">15818558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heys SD, Smith IC, Ross JA, Gilbert FJ, Brooks J, Semple S, Miller ID, Hutcheon A, Sarkar T, Eremin O. A pilot study with long term follow up of hyperbaric oxygen pretreatment in patients with locally advanced breast cancer undergoing neo-adjuvant chemotherapy. Undersea Hyperb Med. 2006;33:33–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16602255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chong KT, Hampson NB, Bostwick DG, Vessella RL, Corman JM. Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: implications for the treatment of radiation-induced haemorrhagic cystitis. BJU Int. 2004;94:1275–1278. doi: 10.1111/j.1464-410X.2004.05156.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1464-410X.2004.05156.x</ArticleId>
            <ArticleId IdType="pubmed">15610104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schonmeyr BH, Wong AK, Reid VJ, Gewalli F, Mehrara BJ. The effect of hyperbaric oxygen treatment on squamous cell cancer growth and tumor hypoxia. Ann Plast Surg. 2008;60:81–88. doi: 10.1097/SAP.0b013e31804a806a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/SAP.0b013e31804a806a</ArticleId>
            <ArticleId IdType="pubmed">18281803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thom, SR (2011) Hyperbaric oxygen: its mechanisms and efficacy. Plas Recon Surg 127 Suppl 1:131S–141S</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3058327</ArticleId>
            <ArticleId IdType="pubmed">21200283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang H, Zhang ZY, Ge JP, Zhou WQ, Gao JP. Effects of hyperbaric oxygen on tumor growth in the mouse model of LNCaP prostate cancer cell line. Zhonghua Nan Ke Xue. 2009;15:713–716.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19852272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson R, Lauchlan SC (1966) Epidermoid carcinoma of the cervix treated by 60Co therapy and hyperbaric oxygen. In: Proceedings Int Cong of Hyperb Med, pp. 648–652</Citation>
        </Reference>
        <Reference>
          <Citation>Feldmeier JJ, Heimbach RD, Davolt DA, Brakora MJ, Sheffield PJ, Porter AT. Does hyperbaric oxygen have a cancer-causing or -promoting effect? A review of the pertinent literature. Undersea Hyperb Med. 1994;21:467–475.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8000286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res. 2011;728:23–34. doi: 10.1016/j.mrrev.2011.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mrrev.2011.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC4028085</ArticleId>
            <ArticleId IdType="pubmed">21605699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haroon AT, Patel M, Al-Mehdi AB. Lung metastatic load limitation with hyperbaric oxygen. Undersea Hyperb Med. 2007;34:83–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17520859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moen I, Jevne C, Wang J, Kalland KH, Chekenya M, Akslen LA, Sleire L, Enger PO, Reed RK, Oyan AM, Stuhr LE. Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. BMC Cancer. 2012;12:21. doi: 10.1186/1471-2407-12-21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2407-12-21</ArticleId>
            <ArticleId IdType="pmc">PMC3274430</ArticleId>
            <ArticleId IdType="pubmed">22251838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daruwalla J, Christophi C. The effect of hyperbaric oxygen therapy on tumour growth in a mouse model of colorectal cancer liver metastases. Eur J Cancer. 2006;42:3304–3311. doi: 10.1016/j.ejca.2006.08.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejca.2006.08.004</ArticleId>
            <ArticleId IdType="pubmed">17010602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daruwalla J, Greish K, Nikfarjam M, Millar I, Malcontenti-Wilson C, Iyer AK, Christophi C. Evaluation of the effect of SMA-pirarubicin micelles on colorectal cancer liver metastases and of hyperbaric oxygen in CBA mice. J Drug Target. 2007;15:487–495. doi: 10.1080/10611860701499839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/10611860701499839</ArticleId>
            <ArticleId IdType="pubmed">17671895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Bock K, Mazzone M, Carmeliet P. Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? Nat Rev Clin Oncol. 2011;8:393–404. doi: 10.1038/nrclinonc.2011.83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrclinonc.2011.83</ArticleId>
            <ArticleId IdType="pubmed">21629216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev. 1994;13:139–168. doi: 10.1007/BF00689633.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00689633</ArticleId>
            <ArticleId IdType="pubmed">7923547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Waili NS, Betler G, Beale J, Hamilton RW, Lee BY, Lucas P. Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. MedSciMonit. 2005;11:RA279–RA289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16127374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohgami Y, Elstad CA, Chung E, Shirachi DY, Quock RM, Lai HC. Effect of hyperbaric oxygen on the anticancer effect of artemisinin on molt-4 human leukemia cells. Anticancer Res. 2010;30:4467–4470.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21115894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki Y, Tanaka K, Negishi D, Shimizu M, Yoshida Y, Hashimoto T, Yamazaki H. Pharmacokinetic investigation of increased efficacy against malignant gliomas of carboplatin combined with hyperbaric oxygenation. Neurol Med Chir (Tokyo) 2009;49:193–197. doi: 10.2176/nmc.49.193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2176/nmc.49.193</ArticleId>
            <ArticleId IdType="pubmed">19465788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohguri T, Imada H, Narisada H, Yahara K, Morioka T, Nakano K, Miyaguni Y, Korogi Y. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results. Int J Hyperthermia. 2009;25:160–167. doi: 10.1080/02656730802610357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/02656730802610357</ArticleId>
            <ArticleId IdType="pubmed">19337916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Selvendiran K, Kuppusamy ML, Ahmed S, Bratasz A, Meenakshisundaram G, Rivera BK, Khan M, Kuppusamy P. Oxygenation inhibits ovarian tumor growth by downregulating STAT3 and cyclin-D1 expressions. Cancer Biol Ther. 2010;10:386–390. doi: 10.4161/cbt.10.4.12448.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/cbt.10.4.12448</ArticleId>
            <ArticleId IdType="pubmed">20562529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stuhr LE, Iversen VV, Straume O, Maehle BO, Reed RK. Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors. Cancer Lett. 2004;210:35–40. doi: 10.1016/j.canlet.2004.02.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2004.02.012</ArticleId>
            <ArticleId IdType="pubmed">15172118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moen I, Tronstad KJ, Kolmannskog O, Salvesen GS, Reed RK, Stuhr LE. Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma. BMC Cancer. 2009;9:446. doi: 10.1186/1471-2407-9-446.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2407-9-446</ArticleId>
            <ArticleId IdType="pmc">PMC2805681</ArticleId>
            <ArticleId IdType="pubmed">20017908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–10874. doi: 10.1073/pnas.191367098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.191367098</ArticleId>
            <ArticleId IdType="pmc">PMC58566</ArticleId>
            <ArticleId IdType="pubmed">11553815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature. 2000;406:747–752. doi: 10.1038/35021093.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35021093</ArticleId>
            <ArticleId IdType="pubmed">10963602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jevne CMI, Salvesen G, Reed RK, Stuhr LEB. A reduction in the interstitial fluid pressure per se, does not enhance the uptake of the small molecule weight compound 5-fluorouracil into 4T1 mammary tumours. Drug Ther Stud. 2011;1:10–14.</Citation>
        </Reference>
        <Reference>
          <Citation>Suzuki Y, Tanaka K, Neghishi D, Shimizu M, Murayama N, Hashimoto T, Yamazaki H. Increased distribution of carboplatin, an anti-cancer agent, to rat brains with the aid of hyperbaric oxygenation. Xenobiotica. 2008;38:1471–1475. doi: 10.1080/00498250802478313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00498250802478313</ArticleId>
            <ArticleId IdType="pubmed">18949658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayer R, Hamilton-Farrell MR, van der Kleij AJ, Schmutz J, Granstrom G, Sicko Z, Melamed Y, Carl UM, Hartmann KA, Jansen EC, Ditri L, Sminia P. Hyperbaric oxygen and radiotherapy. Strahlenther Onkol. 2005;181:113–123. doi: 10.1007/s00066-005-1277-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00066-005-1277-y</ArticleId>
            <ArticleId IdType="pubmed">15702300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kindwall E.  Hyperb medicine practice. 2. Flagstaff: Best; 2002. </Citation>
        </Reference>
        <Reference>
          <Citation>Bennett MH, Feldmeier J, Smee R, Milross C. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. Cochrane Database Syst Rev. 2012;4:CD005007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6457774</ArticleId>
            <ArticleId IdType="pubmed">22513926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kohshi K, Kinoshita Y, Imada H, Kunugita N, Abe H, Terashima H, Tokui N, Uemura S. Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas. Br J Cancer. 1999;80:236–241. doi: 10.1038/sj.bjc.6690345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjc.6690345</ArticleId>
            <ArticleId IdType="pmc">PMC2363018</ArticleId>
            <ArticleId IdType="pubmed">10390002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyle P., Levin B. (eds) (2008) World cancer report. IARC, Lyon</Citation>
        </Reference>
        <Reference>
          <Citation>Suit HD, Maeda M. Hyperbaric oxygen and radiobiology of a C3H mouse mammary carcinoma. J Natl Cancer Inst. 1967;39:639–652.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18623926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCredie JA, Inch WR, Kruuv J, Watson TA. Effects of hyperbaric oxygen on growth and metastases of the C3HBA tumor in the mouse. Cancer. 1966;19:1537–1542. doi: 10.1002/1097-0142(196611)19:11&lt;1537::AID-CNCR2820191113&gt;3.0.CO;2-S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1097-0142(196611)19:11&lt;1537::AID-CNCR2820191113&gt;3.0.CO;2-S</ArticleId>
            <ArticleId IdType="pubmed">5925261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shewell J, Thompson SC. The effect of hyperbaric oxygen treatment on pulmonary metastasis in the C3H mouse. Eur J Cancer. 1980;16:253–259. doi: 10.1016/0014-2964(80)90157-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0014-2964(80)90157-7</ArticleId>
            <ArticleId IdType="pubmed">7371681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kluft O.  Hyperbaric oxygen in experimental cancer in mice. Amsterdam: Universiteit van Amsterdam; 1965. </Citation>
        </Reference>
        <Reference>
          <Citation>National Cancer Institute (2011). Available from http://www.cancer.gov/cancertopics/types/head-and-neck</Citation>
        </Reference>
        <Reference>
          <Citation>National Cancer Institute (2011). Available from http://www.cancer.gov/cancertopics/types/colon-and-rectal</Citation>
        </Reference>
        <Reference>
          <Citation>Watson AJ, Collins PD. Colon cancer: a civilization disorder. Dig Dis. 2011;29:222–228. doi: 10.1159/000323926.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000323926</ArticleId>
            <ArticleId IdType="pubmed">21734388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dische S, Senanayake F. Radiotherapy using hyperbaric oxygen in the palliation of carcinoma of colon and rectum. Clin Radiol. 1972;23:512–518. doi: 10.1016/S0009-9260(72)80032-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0009-9260(72)80032-1</ArticleId>
            <ArticleId IdType="pubmed">4117277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hjelde A, Gederaas OA, Krokan HE, Brubakk AO. Lack of effect of hyperoxia on photodynamic therapy and lipid peroxidation in three different cancer cell lines. Med Sci Monit. 2005;11:BR351–BR356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16192892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maier A, Anegg U, Fell B, Rehak P, Ratzenhofer B, Tomaselli F, Sankin O, Pinter H, Smolle-Juttner FM, Friehs GB. Hyperbaric oxygen and photodynamic therapy in the treatment of advanced carcinoma of the cardia and the esophagus. Lasers Surg Med. 2000;26:308–315. doi: 10.1002/(SICI)1096-9101(2000)26:3&lt;308::AID-LSM9&gt;3.0.CO;2-B.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-9101(2000)26:3&lt;308::AID-LSM9&gt;3.0.CO;2-B</ArticleId>
            <ArticleId IdType="pubmed">10738294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong GC, Hu SX, Zhao GY, Gao SZ, Wu LR. Experimental study on cytotoxic effects of hyperbaric oxygen and photodynamic therapy on mouse transplanted tumor. Chin Med J (Engl) 1987;100:697–702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2964998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maier A, Tomaselli F, Anegg U, Rehak P, Fell B, Luznik S, Pinter H, Smolle-Juttner FM. Combined photodynamic therapy and hyperbaric oxygenation in carcinoma of the esophagus and the esophago-gastric junction. Eur J Cardiothorac Surg. 2000;18:649–654. doi: 10.1016/S1010-7940(00)00592-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1010-7940(00)00592-3</ArticleId>
            <ArticleId IdType="pubmed">11113670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Q, Huang Z, Chen H, Shapiro H, Beckers J, Hetzel FW. Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy. Photochem Photobiol. 2002;76:197–203. doi: 10.1562/0031-8655(2002)076&lt;0197:IOTRBM&gt;2.0.CO;2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1562/0031-8655(2002)076&lt;0197:IOTRBM&gt;2.0.CO;2</ArticleId>
            <ArticleId IdType="pubmed">12194217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jirsa M, Jr, Pouckova P, Dolezal J, Pospisil J, Jirsa M. Hyperbaric oxygen and photodynamic therapy in tumour-bearing nude mice. Eur J Cancer. 1991;27:109. doi: 10.1016/0277-5379(91)90075-O.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0277-5379(91)90075-O</ArticleId>
            <ArticleId IdType="pubmed">1826432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4:278–299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1920665</ArticleId>
            <ArticleId IdType="pubmed">12356358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferguson SD. Malignant gliomas: diagnosis and treatment. Dis Mon. 2011;57:558–569. doi: 10.1016/j.disamonth.2011.08.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.disamonth.2011.08.020</ArticleId>
            <ArticleId IdType="pubmed">22036112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beppu T, Tanaka K, Kohshi K. Hyperbaric oxygenation for treatment of glioma. Gan To Kagaku Ryoho. 2011;38:933–936.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21751528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kohshi K, Yamamoto H, Nakahara A, Katoh T, Takagi M. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas. J Neurooncol. 2007;82:297–303. doi: 10.1007/s11060-006-9283-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11060-006-9283-1</ArticleId>
            <ArticleId IdType="pubmed">17120158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogawa K, Yoshii Y, Inoue O, Toita T, Saito A, Kakinohana Y, Adachi G, Iraha S, Tamaki W, Sugimoto K, Hyodo A, Murayama S. Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas. Brit J of Cancer. 2006;95:862–868. doi: 10.1038/sj.bjc.6603342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjc.6603342</ArticleId>
            <ArticleId IdType="pmc">PMC2360529</ArticleId>
            <ArticleId IdType="pubmed">16953239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Cancer Institute. Available from http://www.cancer.gov/cancertopics/types/leukemia</Citation>
        </Reference>
        <Reference>
          <Citation>Tonomura N, Granowitz EV. Hyperbaric oxygen: a potential new therapy for leukemia? Leuk Res. 2007;31:745–746. doi: 10.1016/j.leukres.2006.11.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.leukres.2006.11.020</ArticleId>
            <ArticleId IdType="pubmed">17275904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson RJ, Wiseman N, Lauchlan SC. The effect of hyperbaric oxygen on tumour metastases in mice. Clin Radiol. 1971;22:538–540. doi: 10.1016/S0009-9260(71)80131-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0009-9260(71)80131-9</ArticleId>
            <ArticleId IdType="pubmed">5135823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson RE, Kagan AR, Bryant TL. Hyperbaric oxygen effect on experimental tumor growth. Radiology. 1967;88:775–777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6020944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang H, Sun Y, Xu C, Zhou T, Gao X, Wang L. Effects of hyperbaric oxygen therapy on tumor growth in murine model of PC-3 prostate cancer cell line. Urology. 2009;73:205–208. doi: 10.1016/j.urology.2008.04.057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.urology.2008.04.057</ArticleId>
            <ArticleId IdType="pubmed">18579187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalns J, Krock L, Piepmeier E., Jr The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. Anticancer Res. 1998;18:363–367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9568104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalns JE, Piepmeier EH. Exposure to hyperbaric oxygen induces cell cycle perturbation in prostate cancer cells. In Vitro Cell Dev Biol Anim. 1999;35:98–101. doi: 10.1007/s11626-999-0008-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11626-999-0008-6</ArticleId>
            <ArticleId IdType="pubmed">10475264</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
